## TXN: Texas Instruments Incorporated - XLK: Technology

### Executive Summary

No thesis match: MRS_20 3.7% below STRENGTH zone (4.0-10.0%); PEG 1.57 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.1% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($168.22)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bearish (Bullish: 1, Bearish: 4)

**1. Texas Instruments (TXN) Stock News Today: Goldman Sachs Downgrade, Sherman Fab Ramp, and Wall Street Forecasts (Dec. 16, 2025)**
- Source: ts2.tech | 20251216T180924 | Neutral | Relevance: 100%
- Texas Instruments (TXN) is navigating contrasting forces as Goldman Sachs downgrades its stock to Sell with a cut price target due to concerns over inventory, depreciation, and slower analog chip recovery. Meanwhile, the company celebrates a significant milestone with its Sherman, Texas, semiconductor factory expected to begin production this week, reinforcing its long-term manufacturing strategy. Investors are weighing the immediate financial optics of capacity investments against the strategic advantage of its U.S. manufacturing buildout.

**2. Texas Instruments Inc (NASDAQ:TXN) Gets Double Downgraded**
- Source: FXDailyReport.Com | 20251216T170851 | Bearish | Relevance: 100%
- Goldman Sachs has double downgraded Texas Instruments Inc (NASDAQ:TXN) to Sell from Buy, citing "lackluster" execution and less leverage than peers in the semiconductor upcycle. The firm set a new price target of $156, down from $200. Goldman Sachs analysts believe the company's strategic capacity and capital choices will hinder its margin and earnings recovery relative to competitors.

**3. Texas Instruments Stock (TXN) Slips After Goldman Sachs Double Downgrade: Today’s News, 2026 Forecasts, Analyst Targets, and Key Risks**
- Source: ts2.tech | 20251215T203746 | Bearish | Relevance: 100%
- Texas Instruments (TXN) stock declined after Goldman Sachs issued a rare "double downgrade," lowering its rating to "Sell" with a reduced price target of $156 due to concerns over TI's manufacturing capacity, elevated inventory, and depreciation pressure impacting future margins and free cash flow. While the analog market is recovering, Goldman Sachs believes TI's specific strategic choices may limit its upside compared to peers, emphasizing the debate between long-term competitiveness from capital expenditures and near-term financial headwinds. The company's significant investment in U.S. manufacturing presents both a bull case for cost structure and supply assurance and a bear case regarding margin pressure during a slow demand recovery.

**4. Chipmaker Texas Instruments (TXN) Hit with Rare ‘Double Downgrade’ by Goldman Sachs**
- Source: TipRanks | 20251215T180858 | Bearish | Relevance: 100%
- Goldman Sachs has issued a rare "double downgrade" for Texas Instruments (TXN) stock, moving it from Buy to Sell. The investment bank argues that TXN is poorly positioned to benefit from the AI boom, as its focus on industrial and automotive chips rather than AI-driven technologies limits its growth potential compared to rivals like Nvidia. Goldman Sachs analyst James Schneider also expects the company's "record levels" of inventory and strategic capacity choices to hinder margin and earnings recovery.

**5. $40B semiconductor plant to start production this week in North Texas**
- Source: WFAA | 20251215T180449 | Bullish | Relevance: 100%
- Texas Instruments' $40 billion semiconductor factory in Sherman, Texas, is set to begin production this week after years of construction. The facility, which is the first of four planned plants, will create approximately 3,000 new jobs and is expected to produce tens of millions of chips daily for various electronics. Upon completion, the campus is projected to be the largest electronics production facility in Texas and among the largest manufacturing facilities in the country.

### Analyst Activity

**Target Signal:** VERY_BEARISH (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-15 | Goldman Sachs | $156 | $200 | -22% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-15 | Goldman Sachs | down | Sell |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 4 ($0.58M) |
| Sells | 4 ($0.52M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 42.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 10.6% (+1.1%)
- Blackrock Inc.: 8.5% (+0.1%)
- JPMORGAN CHASE & CO: 6.0% (+80.5%)
- State Street Corpora: 4.8% (+0.5%)
- Charles Schwab Inves: 2.5% (+3.9%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- New product launch cycle could drive revenue acceleration.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.57 elevated, pricing in significant growth expectations. Forward P/E 29.0x stretched relative to 12% growth. Quality metrics strong (ROE 30%, ROA 11%, margin 29%). Balance sheet: strong liquidity (4.5x). Analyst sentiment negative (1 target cuts vs 0 raises). Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $161.4B |
| Beta | 0.99 |
| 52W Range | $139.95 - $221.69 |
| Short Interest | 2.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.57 |
| Forward P/E | 29.0 |
| Current P/E | 32.4 |
| YoY Growth | 11.8% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 5.8% to 3.7% (-2.1% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 0.3pp (needs >4.0% for momentum thesis). MRS_5 (-0.3%) diverging from MRS_20 - short-term weakness emerging. AM_20 at 3.5% shows strong absolute momentum above own 20MA. Outperforming sector by 4.0pp, stock-specific strength. Below SMA200 (0.98x), long-term trend not supportive. MACD histogram positive (0.69), confirming momentum. RSI neutral at 58. OFD pattern: -SLN (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 3.69% (CS: 75) | Neutral |
| RSI_14 | 57.8 | Neutral |
| MACD Histogram | 0.69 | Bullish |
| vs SMA20 | 1.035x | Above |
| vs SMA50 | 1.048x | Above |
| vs SMA200 | 0.976x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $177.56
- **Stop Loss:** $168.22 (5.3% risk)
- **Target:** $186.90 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 107
- **Position Value:** $18,998.92
- **Portfolio %:** 19.00%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with balanced risk positioning. VIX remains calm at 16.48 while breadth shows modest improvement to 52%, indicating neither euphoria nor distress. Mixed sectoral themes from energy weakness to AI expansion suggest stock-picking environment rather than broad directional moves.*

### Earnings

**Next:** 2026-01-20 (Est: $1.31)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.49 | $1.48 | -0.4% |
| 2025Q2 | $1.33 | $1.41 | +5.8% |
| 2025Q1 | $1.06 | $1.28 | +20.2% |
| 2024Q4 | $1.20 | $1.30 | +8.3% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*